ストックスクリーナーアプリを入手
3.64
32.84%
-1.78
Jupiter Neurosciences Inc (JUNS) 最新ニュース
Jupiter Neurosciences refocuses on NLRP3 inflammasome By Investing.com - Investing.com South Africa
Jupiter Neurosciences refocuses on NLRP3 inflammasome - Investing.com India
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials - GlobeNewswire
Jupiter Neurosciences announces focus on NLRP3 pathway in JOTROL trials - TipRanks
Jupiter Neurosciences Targets NLRP3 Inflammasome With JOTROL Platform for Alzheimer's Treatment - StockTitan
Jupiter Neurosciences Inc. (JUNS) reports earnings - Quartz
Jupiter Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Jupiter Neurosciences inks deal for Southeast Asia expansion By Investing.com - Investing.com Australia
Jupiter Neurosciences inks deal for Southeast Asia expansion - Investing.com
Jupiter Neurosciences adjusts CFO compensation - Investing.com
Greenridge sees upside in Jupiter Neurosciences stock By Investing.com - Investing.com Canada
Finance Watch: FOPO Surge Continues With Big Offerings From Revolution, NewAmsterdam - Citeline News & Insights
Tesla, Nvidia among Tuesday's market cap stock movers - Investing.com
Tesla, Nvidia among Tuesday's market cap stock movers By Investing.com - Investing.com UK
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday - Benzinga
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Marvell, Credo Tech lead Friday's market cap stock movers By Investing.com - Investing.com South Africa
Marvell, Credo Tech lead Friday's market cap stock movers - Investing.com India
Adobe, Ciena lead Thursday's market cap stock movers By Investing.com - Investing.com South Africa
Adobe, Ciena lead Thursday's market cap stock movers - Investing.com
Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On ThursdayAkso Health (NASDAQ:AHG), Bloom Energy (NYSE:BE) - Benzinga
Opening Day: Jinxin Technology, zSpace make public debut - MSN
U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha
IPO NewsUS IPO Weekly Recap: ServiceTitan launches as small issuers slip through the IPO window - Renaissance Capital
Rx Rundown: Eli Lilly, Amgen, GSK and more - MM+M Online
Company behind novel Parkinson's disease treatment raises $11 million in IPO - The Business Journals
Jupiter IPOs to advance resveratrol-based treatments for neuroinflammation - Longevity.Technology
Grupo Aeroportuario del Pacifico Reports in November 2024 a Passenger Traffic Increase of 1.8% Compared to 2023 - The Manila Times
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering - GlobeNewswire
Jupiter Neurosciences Launches $11M IPO to Advance Parkinson's Disease Treatment Pipeline - StockTitan
Sumitomo Chemical Transfers Subsidiary Shares to GE HealthCare - MSN
IPO Roundup: Fast Track Group, MasterBeef and more - MSN
G50 Corp to Present at Sydney Investor Conference - MSN
Gildan Activewear, Inc. (GIL) Hit a 52 Week High, Can the Run Continue? - MSN
Aclaris Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference - MSN
Tri Chemical Laboratories Reports Strong Financial Gains - MSN
Broadridge Stock Rises 11% in a Month: What You Should Know - MSN
Arteris, Inc. (AIP) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Dragon Rise Group Reports Revenue Surge, Holds Dividends - MSN
Apollo’s Novolex Explores Offer for Pactiv Evergreen - MSN
Jupiter Neurosciences stock rallies 37% following $11M IPO - MSN
2024's 10 Best-Performing Stocks - MSN
Why Accenture Stock Slumped Today - MSN
Agenus (AGEN) Stock Drops 5.50% Amid Biotech Sector Decline - GuruFocus.com
Morgan Stanley Upgrades Axon Enterprise (AXON) - MSN
Porch Stock Rockets After Firm Announces Upbeat Financial Targets Ahead Of Investor Day: Retail Sentiment Soars - MSN
Fastly price target raised to $10 from $8 at Piper Sandler - MSN
JUNS IPO NewsNeuro-inflammation biotech Jupiter Neurosciences prices IPO at $4, the low end of the range - Renaissance Capital
Don't Miss the Buying Opportunity in This Dividend King, Says Analyst - MSN
JUNSJUNS Latest Stock News & Market Updates - StockTitan
Jupiter Neurosciences Launches $11M IPO for Parkinson's Drug Development - StockTitan
Innovator ETFs® Announces Closure of ETFs - The Manila Times
Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq - GlobeNewswire
Some Atlantic City casino workers call on union boss to resign for opposing a smoking ban - Yahoo Canada Finance
0.70%
7.63%
大文字化:
|
ボリューム (24 時間):